Short Interest in Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Declines By 88.3%

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 20,500 shares, a drop of 88.3% from the August 15th total of 174,700 shares. Based on an average trading volume of 117,050,500 shares, the days-to-cover ratio is currently 0.0 days.

Therapeutic Solutions International Price Performance

Therapeutic Solutions International stock opened at $0.00 on Friday. Therapeutic Solutions International has a 12 month low of $0.00 and a 12 month high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.